Quarterly report pursuant to sections 13 or 15(d)

Document and Entity Information

Document and Entity Information
6 Months Ended
Jun. 30, 2011
Jul. 11, 2012
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag true  
AmendmentDescription The purpose of this Amendment No. 3 (the “Amendment”) to MusclePharm Corporation’s (the “Company”) quarterly report on Form 10-Q/A for the period ended June 30, 2011, originally filed with the U.S. Securities and Exchange Commission on July 2, 2012 (the “Form 10-Q”), is solely to: (i) restate previous scrivener’s and typographical errors in the Company’s consolidated balance sheet; and (ii) furnish Exhibit 101 to the Form 10-Q/A in accordance with Rule 405 of Regulation S-T. No other changes have been made in this Amendment to the Form 10-Q/A. This Amendment speaks as of the original date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date and does not modify or update in any way disclosures made in the original Form 10-Q. Pursuant to Rule 406T of Regulation S–T, the interactive data files on Exhibit 101 attached hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Act of 1934, as amended, and otherwise are not subject to liability under those sections.  
Document Period End Date Jun. 30, 2011  
Document Fiscal Year Focus 2011  
Document Fiscal Period Focus Q2  
Trading Symbol MSLP  
Entity Registrant Name MUSCLEPHARM CORP  
Entity Central Index Key 0001415684  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   1,399,074,207